Cat
Name
Size
Price
Action
9-47062
Human Fat PrimaCell™1: Normal Adipose Cells Growth Supplements with Serum (for 500 mL medium)
Set
Ask
9-26043
Rat Fat PrimaCell™1: Normal Adipose Cells Growth Supplements with Serum (for 500 mL medium)
Set
Ask
9-33042
Mouse Fat PrimaCell™1: Normal Adipose Cells Growth Supplements with Serum (for 500 mL medium)
Set
Ask
MBS6308334-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (FITC)
0.2 mL
Ask
MBS6308334-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (FITC)
5x 0.2 mL
Ask
MBS6308338-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 550)
0.1 mL
Ask
MBS6308338-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 550)
5x 0.1 mL
Ask
MBS6381654-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (HRP)
0.1 mL
Ask
MBS6381654-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (HRP)
5x 0.1 mL
Ask
MBS6001811-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
0.1 mg
Ask
MBS6001811-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
5x 0.1 mg
Ask
MBS6137050-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) APC
0.1 mL
Ask
MBS6137050-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) APC
5x 0.1 mL
Ask
MBS6009757-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65)
0.2 mL
Ask
MBS6009757-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65)
5x 0.2 mL
Ask
MBS6002843-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
0.1 mg
Ask
MBS6002843-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
5x 0.1 mg
Ask
MBS6152959-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (HRP)
0.1 mL
Ask
MBS6152959-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (HRP)
5x 0.1 mL
Ask
MBS6308337-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 490)
0.1 mL
Ask
MBS6308337-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 490)
5x 0.1 mL
Ask
MBS6308339-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 650)
0.1 mL
Ask
MBS6308339-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 650)
5x 0.1 mL
Ask
MBS6131747-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (AP)
0.1 mL
Ask
MBS6131747-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (AP)
5x 0.1 mL
Ask
MBS6158262-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (PE)
0.1 mL
Ask
MBS6158262-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (PE)
5x 0.1 mL
Ask
MBS6381660-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (PE)
0.1 mL
Ask
MBS6381660-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (PE)
5x 0.1 mL
Ask
MBS6308331-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (AP)
0.2 mL
Ask
MBS6308331-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (AP)
5x 0.2 mL
Ask
MBS6308332-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (APC)
0.2 mL
Ask
MBS6308332-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (APC)
5x 0.2 mL
Ask
MBS6308333-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (Biotin)
0.2 mL
Ask
MBS6308333-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (Biotin)
5x 0.2 mL
Ask
MBS6308335-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (HRP)
0.2 mL
Ask
MBS6308335-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (HRP)
5x 0.2 mL
Ask
MBS6308336-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 405)
0.1 mL
Ask
MBS6308336-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 405)
5x 0.1 mL
Ask
MBS6308340-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 750)
0.1 mL
Ask
MBS6308340-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (MaxLight 750)
5x 0.1 mL
Ask
MBS6308341-01
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (PE)
0.2 mL
Ask
MBS6308341-02
HRASLS3, CT (PLA2G16, HRASLS3, HREV107, Group XVI phospholipase A1/A2, Adipose-specific phospholipase A2, H-rev 107 protein homolog, HRAS-like suppressor 1, HRAS-like suppressor 3, HREV107-1, HREV107-3, Renal carcinoma antigen NY-REN-65) (PE)
5x 0.2 mL
Ask
MBS6381650-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (AP)
0.1 mL
Ask
MBS6381650-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (AP)
5x 0.1 mL
Ask
MBS6381651-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) APC
0.1 mL
Ask
MBS6381651-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) APC
5x 0.1 mL
Ask
MBS6381653-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (FITC)
0.1 mL
Ask
MBS6381653-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (FITC)
5x 0.1 mL
Ask
MBS6147656-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (FITC)
0.1 mL
Ask
MBS6147656-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (FITC)
5x 0.1 mL
Ask
MBS6003669-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
0.05 mg
Ask
MBS6003669-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754)
5x 0.05 mg
Ask
MBS6201285-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6201285-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6381656-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381656-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6381658-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381658-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6233310-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6233310-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6190610-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6190610-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6222635-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6222635-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6381652-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (Biotin)
0.1 mL
Ask
MBS6381652-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (Biotin)
5x 0.1 mL
Ask
MBS6381657-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381657-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6381655-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381655-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6381659-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6381659-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6211960-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
0.1 mL
Ask
MBS6211960-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (MaxLight
5x 0.1 mL
Ask
MBS6142353-01
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (Biotin)
0.1 mL
Ask
MBS6142353-02
HRASLS3 (PLA2G16, HRASLS3, HREV107, Group XVI Phospholipase A1/A2, Adipose-specific Phospholipase A2, H-rev 107 Protein Homolog, HRAS-like Suppressor 1, HRAS-like Suppressor 3, HREV107-1, HREV107-3, Renal Carcinoma Antigen NY-REN-65, MGC118754) (Biotin)
5x 0.1 mL
Ask
MBS630473-01
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
0.1 mg
Ask
MBS630473-02
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
5x 0.1 mg
Ask
MBS645591-01
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
0.1 mg
Ask
MBS645591-02
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
5x 0.1 mg
Ask
MBS644621-01
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3, MGC118754)
0.1 mL
Ask
MBS644621-02
PLA2G16 (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3, MGC118754)
5x 0.1 mL
Ask
MBS6011519-01
PLA2G16, NT (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
0.05 mg
Ask
MBS6011519-02
PLA2G16, NT (Group XVI Phospholipase A2, Adipose-specific Phospholipase A2, AdPLA, H-rev 107 Protein Homolog, HRAS-like Suppressor 3, HREV107, HREV107-3, Renal Carcinoma Antigen NY-REN-65, HRASLS3)
5x 0.05 mg
Ask